Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048381575> ?p ?o ?g. }
- W3048381575 endingPage "e000374" @default.
- W3048381575 startingPage "e000374" @default.
- W3048381575 abstract "Background Despite the great achievements made in immune-checkpoint-blockade (ICB) in cancer therapy, there are no effective predictive biomarkers in gastrointestinal (GI) cancer. Methods This study included 93 metastatic GI patients treated with ICBs. The first cohort comprising 73 GI cancer patients were randomly assigned into discovery (n=44) and validation (n=29) cohorts. Comprehensive genomic profiling was performed on all samples to determine tumor mutational burden (TMB) and copy-number alterations (CNAs). A subset of samples was collected for RNA immune oncology (IO) panel sequencing, microsatellite instability (MSI)/mismatch repair and program death ligand 1 (PD-L1) expression evaluation. In addition, 20 gastric cancer (GC) patients were recruited as the second validation cohort. Results In the first cohort of 73 GI cancer patients, a lower burden of CNA was observed in patients with durable clinical benefit (DCB). In both the discovery (n=44) and validation (n=29) subsets, lower burden of CNA was associated with an improved clinical benefit and better overall survival (OS). Efficacy also correlated with a higher TMB. Of note, a combinatorial biomarker of TMB and CNA may better stratify DCB patients from ICB treatment, which was further confirmed in the second validation cohort of 20 GC patients. Finally, patients with lower burden of CNA revealed increased immune signatures in our cohort and The Cancer Genome Atlas data sets as well. Conclusions Our results suggest that the burden of CNA may have superior predictive value compared with other signatures, including PD-L1, MSI and TMB. The joint biomarker of CNA burden and TMB may better stratify DCB patients, thereby providing a rational choice for GI patients treated with ICBs." @default.
- W3048381575 created "2020-08-18" @default.
- W3048381575 creator A5001258628 @default.
- W3048381575 creator A5006511913 @default.
- W3048381575 creator A5015849886 @default.
- W3048381575 creator A5035535613 @default.
- W3048381575 creator A5038853266 @default.
- W3048381575 creator A5044063199 @default.
- W3048381575 creator A5046118596 @default.
- W3048381575 creator A5046183787 @default.
- W3048381575 creator A5052883326 @default.
- W3048381575 creator A5059392900 @default.
- W3048381575 creator A5061084605 @default.
- W3048381575 creator A5065755796 @default.
- W3048381575 creator A5073995543 @default.
- W3048381575 creator A5079003453 @default.
- W3048381575 creator A5079232261 @default.
- W3048381575 creator A5083365013 @default.
- W3048381575 creator A5085111290 @default.
- W3048381575 date "2020-08-01" @default.
- W3048381575 modified "2023-10-14" @default.
- W3048381575 title "Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer" @default.
- W3048381575 cites W1940241680 @default.
- W3048381575 cites W2009720434 @default.
- W3048381575 cites W2038120654 @default.
- W3048381575 cites W2049553585 @default.
- W3048381575 cites W2083581022 @default.
- W3048381575 cites W2107429737 @default.
- W3048381575 cites W2107633226 @default.
- W3048381575 cites W2123879591 @default.
- W3048381575 cites W2125535566 @default.
- W3048381575 cites W2130410032 @default.
- W3048381575 cites W2134297013 @default.
- W3048381575 cites W2152061559 @default.
- W3048381575 cites W2159064822 @default.
- W3048381575 cites W2169744057 @default.
- W3048381575 cites W2291298003 @default.
- W3048381575 cites W2293531514 @default.
- W3048381575 cites W2520028087 @default.
- W3048381575 cites W2559602085 @default.
- W3048381575 cites W2564351475 @default.
- W3048381575 cites W2574604975 @default.
- W3048381575 cites W2593030814 @default.
- W3048381575 cites W2606495925 @default.
- W3048381575 cites W2618060945 @default.
- W3048381575 cites W2622499649 @default.
- W3048381575 cites W2626033245 @default.
- W3048381575 cites W2635951006 @default.
- W3048381575 cites W2655262992 @default.
- W3048381575 cites W2747774814 @default.
- W3048381575 cites W2753306770 @default.
- W3048381575 cites W2763701359 @default.
- W3048381575 cites W2790164909 @default.
- W3048381575 cites W2797675588 @default.
- W3048381575 cites W2889721546 @default.
- W3048381575 cites W2895427447 @default.
- W3048381575 cites W2896640994 @default.
- W3048381575 cites W2897815318 @default.
- W3048381575 cites W2905562353 @default.
- W3048381575 cites W2914335731 @default.
- W3048381575 cites W2972232496 @default.
- W3048381575 cites W2977498449 @default.
- W3048381575 cites W2978609674 @default.
- W3048381575 cites W3002662929 @default.
- W3048381575 cites W4244521339 @default.
- W3048381575 doi "https://doi.org/10.1136/jitc-2019-000374" @default.
- W3048381575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7430454" @default.
- W3048381575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32792358" @default.
- W3048381575 hasPublicationYear "2020" @default.
- W3048381575 type Work @default.
- W3048381575 sameAs 3048381575 @default.
- W3048381575 citedByCount "36" @default.
- W3048381575 countsByYear W30483815752020 @default.
- W3048381575 countsByYear W30483815752021 @default.
- W3048381575 countsByYear W30483815752022 @default.
- W3048381575 countsByYear W30483815752023 @default.
- W3048381575 crossrefType "journal-article" @default.
- W3048381575 hasAuthorship W3048381575A5001258628 @default.
- W3048381575 hasAuthorship W3048381575A5006511913 @default.
- W3048381575 hasAuthorship W3048381575A5015849886 @default.
- W3048381575 hasAuthorship W3048381575A5035535613 @default.
- W3048381575 hasAuthorship W3048381575A5038853266 @default.
- W3048381575 hasAuthorship W3048381575A5044063199 @default.
- W3048381575 hasAuthorship W3048381575A5046118596 @default.
- W3048381575 hasAuthorship W3048381575A5046183787 @default.
- W3048381575 hasAuthorship W3048381575A5052883326 @default.
- W3048381575 hasAuthorship W3048381575A5059392900 @default.
- W3048381575 hasAuthorship W3048381575A5061084605 @default.
- W3048381575 hasAuthorship W3048381575A5065755796 @default.
- W3048381575 hasAuthorship W3048381575A5073995543 @default.
- W3048381575 hasAuthorship W3048381575A5079003453 @default.
- W3048381575 hasAuthorship W3048381575A5079232261 @default.
- W3048381575 hasAuthorship W3048381575A5083365013 @default.
- W3048381575 hasAuthorship W3048381575A5085111290 @default.
- W3048381575 hasBestOaLocation W30483815751 @default.
- W3048381575 hasConcept C104317684 @default.
- W3048381575 hasConcept C121608353 @default.
- W3048381575 hasConcept C126322002 @default.